• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在无法获得个体层面数据时开发 COVID-19 死亡率风险预测模型。

Developing a COVID-19 mortality risk prediction model when individual-level data are not available.

机构信息

Clalit Research Institute, Innovation Division, Clalit Health Services, Toval 40, Ramat-Gan, Israel.

School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Ben-Gurion blvd. 1, Be'er Sheva, Israel.

出版信息

Nat Commun. 2020 Sep 7;11(1):4439. doi: 10.1038/s41467-020-18297-9.

DOI:10.1038/s41467-020-18297-9
PMID:32895375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7477233/
Abstract

At the COVID-19 pandemic onset, when individual-level data of COVID-19 patients were not yet available, there was already a need for risk predictors to support prevention and treatment decisions. Here, we report a hybrid strategy to create such a predictor, combining the development of a baseline severe respiratory infection risk predictor and a post-processing method to calibrate the predictions to reported COVID-19 case-fatality rates. With the accumulation of a COVID-19 patient cohort, this predictor is validated to have good discrimination (area under the receiver-operating characteristics curve of 0.943) and calibration (markedly improved compared to that of the baseline predictor). At a 5% risk threshold, 15% of patients are marked as high-risk, achieving a sensitivity of 88%. We thus demonstrate that even at the onset of a pandemic, shrouded in epidemiologic fog of war, it is possible to provide a useful risk predictor, now widely used in a large healthcare organization.

摘要

在 COVID-19 大流行初期,当还没有 COVID-19 患者的个体数据时,就已经需要风险预测器来支持预防和治疗决策。在这里,我们报告了一种混合策略来创建这样的预测器,该策略结合了基线严重呼吸道感染风险预测器的开发和后处理方法,以将预测结果校准到报告的 COVID-19 病死率。随着 COVID-19 患者队列的积累,该预测器被验证具有良好的区分度(接收者操作特征曲线下面积为 0.943)和校准度(与基线预测器相比有显著提高)。在 5%的风险阈值下,15%的患者被标记为高风险,敏感性为 88%。因此,我们证明,即使在大流行初期,在充满流行病学战争迷雾的情况下,也有可能提供一个有用的风险预测器,该预测器现在已在一个大型医疗机构中广泛使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8900/7477233/a85532959e91/41467_2020_18297_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8900/7477233/9551bdd039c1/41467_2020_18297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8900/7477233/84f41cce22ae/41467_2020_18297_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8900/7477233/58ca1bbdb0c2/41467_2020_18297_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8900/7477233/a85532959e91/41467_2020_18297_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8900/7477233/9551bdd039c1/41467_2020_18297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8900/7477233/84f41cce22ae/41467_2020_18297_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8900/7477233/58ca1bbdb0c2/41467_2020_18297_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8900/7477233/a85532959e91/41467_2020_18297_Fig4_HTML.jpg

相似文献

1
Developing a COVID-19 mortality risk prediction model when individual-level data are not available.在无法获得个体层面数据时开发 COVID-19 死亡率风险预测模型。
Nat Commun. 2020 Sep 7;11(1):4439. doi: 10.1038/s41467-020-18297-9.
2
Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13,323 COVID-19 patients: The Veterans Health Administration COVID-19 (VACO) Index.基于来自 13323 例 COVID-19 患者的现有医疗行政数据开发和验证的 30 天死亡率指数:退伍军人健康管理局 COVID-19(VACO)指数。
PLoS One. 2020 Nov 11;15(11):e0241825. doi: 10.1371/journal.pone.0241825. eCollection 2020.
3
Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation.机器学习预测纽约市新冠肺炎患者队列中的死亡率和危急事件:模型开发与验证
J Med Internet Res. 2020 Nov 6;22(11):e24018. doi: 10.2196/24018.
4
Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.估算疫情早期 SARS-CoV-2 的死亡率:在中国湖北和欧洲六个地区的建模研究。
PLoS Med. 2020 Jul 28;17(7):e1003189. doi: 10.1371/journal.pmed.1003189. eCollection 2020 Jul.
5
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.利用 ISARIC WHO 临床特征协议对因 COVID-19 住院的患者进行风险分层:4C 死亡率评分的制定和验证。
BMJ. 2020 Sep 9;370:m3339. doi: 10.1136/bmj.m3339.
6
Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19.开发和验证一种模型,用于对 4536 例 COVID-19 患者的住院风险进行个体化预测。
PLoS One. 2020 Aug 11;15(8):e0237419. doi: 10.1371/journal.pone.0237419. eCollection 2020.
7
Development and external validation of a prediction risk model for short-term mortality among hospitalized U.S. COVID-19 patients: A proposal for the COVID-AID risk tool.美国住院 COVID-19 患者短期死亡率预测风险模型的开发和外部验证:COVID-AID 风险工具的建议。
PLoS One. 2020 Sep 30;15(9):e0239536. doi: 10.1371/journal.pone.0239536. eCollection 2020.
8
Prediction model and risk scores of ICU admission and mortality in COVID-19.新型冠状病毒肺炎患者 ICU 入住和死亡的预测模型和风险评分。
PLoS One. 2020 Jul 30;15(7):e0236618. doi: 10.1371/journal.pone.0236618. eCollection 2020.
9
High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study.癌症患者院内获得性 COVID-19 感染的高死亡率:一项多中心观察性队列研究。
Eur J Cancer. 2020 Nov;139:181-187. doi: 10.1016/j.ejca.2020.08.017. Epub 2020 Sep 3.
10
Early prediction and identification for severe patients during the pandemic of COVID-19: A severe COVID-19 risk model constructed by multivariate logistic regression analysis.在 COVID-19 大流行期间对重症患者进行早期预测和识别:采用多元逻辑回归分析构建的重症 COVID-19 风险模型。
J Glob Health. 2020 Dec;10(2):020510. doi: 10.7189/jogh.10.020510.

引用本文的文献

1
Harnessing multi-output machine learning approach and dynamical observables from network structure to optimize COVID-19 intervention strategies.利用多输出机器学习方法和网络结构中的动态可观测量来优化新冠肺炎干预策略。
Biol Methods Protoc. 2025 Jun 5;10(1):bpaf039. doi: 10.1093/biomethods/bpaf039. eCollection 2025.
2
A machine learning model exploring the relationship between chronic medication and COVID-19 clinical outcomes.一种探索慢性药物治疗与新冠肺炎临床结局之间关系的机器学习模型。
Int J Clin Pharm. 2025 Aug;47(4):1075-1086. doi: 10.1007/s11096-025-01955-7. Epub 2025 Jul 28.
3
Proton pump inhibitors use and risk of type 2 diabetes mellitus: correlation analysis, prediction model construction, and key genes identification.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度:一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
3
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.
质子泵抑制剂的使用与2型糖尿病风险:相关性分析、预测模型构建及关键基因鉴定
Front Pharmacol. 2025 Apr 29;16:1580090. doi: 10.3389/fphar.2025.1580090. eCollection 2025.
4
A within-host infection model to explore tolerance and resistance.一种用于探索耐受性和抗性的宿主体内感染模型。
Elife. 2025 Feb 13;14:e104052. doi: 10.7554/eLife.104052.
5
Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients-March 2022-April 2023.开发一个预测模型,用于预测退伍军人健康管理局患者队列中 COVID-19 患者 30 天住院和死亡风险-2022 年 3 月至 2023 年 4 月。
PLoS One. 2024 Oct 4;19(10):e0307235. doi: 10.1371/journal.pone.0307235. eCollection 2024.
6
Development and validation of a scoring system to predict the mortality of hospitalized patients with SARS-CoV-2 Omicron: a nationwide, multicentre study.开发和验证一种评分系统以预测住院 SARS-CoV-2 奥密克戎感染者的死亡率:一项全国性多中心研究。
BMC Pulm Med. 2024 Jul 3;24(1):312. doi: 10.1186/s12890-024-03131-5.
7
Performance Drift in Machine Learning Models for Cardiac Surgery Risk Prediction: Retrospective Analysis.用于心脏手术风险预测的机器学习模型中的性能漂移:回顾性分析
JMIRx Med. 2024 Jun 12;5:e45973. doi: 10.2196/45973.
8
Comorbidities and their association with COVID-19 mortality in Mexico between January 2020 and August 2021.2020 年 1 月至 2021 年 8 月期间墨西哥合并症及其与 COVID-19 死亡率的关系。
PLoS One. 2024 Apr 17;19(4):e0296895. doi: 10.1371/journal.pone.0296895. eCollection 2024.
9
The Disconnect Between Development and Intended Use of Clinical Prediction Models for Covid-19: A Systematic Review and Real-World Data Illustration.新型冠状病毒肺炎临床预测模型的开发与预期用途之间的脱节:系统评价与真实世界数据例证
Front Epidemiol. 2022 Jun 27;2:899589. doi: 10.3389/fepid.2022.899589. eCollection 2022.
10
Navigating ethical challenges in psychological research involving digital remote technologies and people who use alcohol or drugs.探索涉及使用酒精或毒品的人群和数字远程技术的心理研究中的伦理挑战。
Am Psychol. 2024 Jan;79(1):24-38. doi: 10.1037/amp0001193.
从中国武汉的传播动态估计 COVID-19 的临床严重程度。
Nat Med. 2020 Apr;26(4):506-510. doi: 10.1038/s41591-020-0822-7. Epub 2020 Mar 19.
4
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.COVID-19 诊断和预后预测模型:系统评价和批判性评估。
BMJ. 2020 Apr 7;369:m1328. doi: 10.1136/bmj.m1328.
5
Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic.关键物资短缺——新冠疫情期间对呼吸机和个人防护装备的需求
N Engl J Med. 2020 Apr 30;382(18):e41. doi: 10.1056/NEJMp2006141. Epub 2020 Mar 25.
6
Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate.尽管新冠病毒的病死率较低,但新冠病毒造成的死亡人数比非典和中东呼吸综合征的死亡人数总和还要多。
BMJ. 2020 Feb 18;368:m641. doi: 10.1136/bmj.m641.
7
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
8
Machine Learning and Prediction in Medicine - Beyond the Peak of Inflated Expectations.医学中的机器学习与预测——超越过高期望的顶峰
N Engl J Med. 2017 Jun 29;376(26):2507-2509. doi: 10.1056/NEJMp1702071.
9
Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests.用于评估预测模型、分子标志物和诊断测试的净效益方法。
BMJ. 2016 Jan 25;352:i6. doi: 10.1136/bmj.i6.
10
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement.透明报告个体预后或诊断的多变量预测模型(TRIPOD):TRIPOD 声明。
Br J Surg. 2015 Feb;102(3):148-58. doi: 10.1002/bjs.9736.